Sign in
4

Changes in Ownership

SCYNEXIS INC Filed Acc 0001209191-22-007727

Chief Medical Officer acquired 51,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Angulo Gonzalez David Chief Medical Officer 2022-02-04 Grant or award +51,100 74,981 D
Derivatives
Angulo Gonzalez David Chief Medical Officer 2022-02-04 Grant or award · Stock Option (Right to Buy) +85,000 85,000 D
Loading xslF345X03/doc4.xml…